Uncovering New Treatments: A Look at Emerging Therapies in Dermatology Trials

Uncovering New Treatments: A Look at Emerging Therapies in Dermatology Trials

dermatology trials

Clinical trials are vital to studying new treatments. At Skin Care Research, you can participate in FDA-regulated dermatology trials that allow you to discover innovative new treatments and the opportunity to be financially rewarded for your involvement.

Emergent Therapies in Dermatology Trials

Ritlecitinib for Vitiligo

Vitiligo is an autoimmune disorder that consists of depigmented patches of skin. In most cases, both sides of the body are affected, which means that if you develop vitiligo on your left hand, the same will occur on your right hand.

Ritlecitinib, a medication used to treat severe alopecia, is being studied for its effects on vitiligo. Researchers think that ritlecitinib disrupts the immune functions that lead to vitiligo. In a study of people with nonsegmental vitiligo, up to 57.9% had improved after 48 weeks. With ritlecitinib, you can manage your vitiligo.

Benzoyl Peroxide Cream for Rosacea

Rosacea is a skin condition notable for redness and swelling in the face. Benzoyl peroxide (BPO) cream is a well-known topical used for acne and is highly effective as a skin treatment. One major drawback of the cream is that it irritates your skin.

Recently, an updated benzoyl peroxide cream for rosacea was released. It is the first rosacea cream with microencapsulation technology that gradually releases BPO. That way, there is more control over the release of medication on your skin, decreasing potential irritation.

Monoclonal Antibodies for Eczema

Some antibodies are being reviewed for their efficacy in treating dermatological diseases. Atopic dermatitis (also called eczema) is an inflammatory condition that causes itching, redness, and cracked skin. Antibody amlitelimab inhibits an immune response regulator, reducing the body’s immune response. In one study, adults with moderate-to-severe eczema saw marked improvements in their symptoms.

Treatments with dupilumab have been studied in adults and teenagers. To evaluate how young children respond to the antibody, investigators have also conducted a clinical trial that showed the antibody is safe for children younger than six years.

Explore Cutting-Edge Dermatology Trials in Florida and Texas

Many exciting developments occur in clinical trials. For dermatology research studies to be successful, participant involvement is crucial. If you suffer from a skin condition and are interested in joining a clinical trial, contact Skin Care Research at 561-948-3116 to participate at one of our convenient locations in Florida and Texas.